PMGC Holdings Inc. Common Stock
ELABStock
$1.09−99.44%52W
Market Cap$4.91M
P/E—
Div yield—
Beta-0.26
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-106.36%
Price vs S&P 500 (4W)-25.60%
VGM Score34.35
Market Capitalization$4.91M
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ELABPMGC Holdings Inc. Common Stock | — | C | F | $1.09 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
PMGC Holdings Inc operates in medical aesthetics and biopharmaceutical innovation, with a focus on skin aesthetics, obesity treatment, and metabolic health. The company develops and commercializes products addressing these growing market segments.